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A persisting enigma is the fact that eholinergic blocking drugs cause 
a "dissociation" between electroencephalographie (EEG) activity and 
gross behavior (BRADLEY and ELKES 1957; WIKLV,~ 1952). Although 
these drugs produce EE G's typical of somnolence or coma, gross behavior 
is apparently unaltered. This finding has led to attempts to determine 
more precisely defined behaviors which are affected by cholinergic 
blocking drugs. 
One of the most intriguing findings is that these agents markedly 
impair the acquisition, but not the retention, of learned behaviors 
(HE~z 1960; M~CRELSO~ 1961). HERZ suggested that this dichotomous 
effect results from a disturbance of recent memory. Indeed, adequate 
doses of atropine (MIGDAL and F~v~I~ 1963; OSTF~LD et al. 1960) and 
scopolamine (GooDMAN and GILMA~ 1955) cause recent memory loss 
in man. 
The fact that eholinergic blocking drugs may cause a recent memory 
loss prompted us to replicate the findings of I-I~z using scopolamine and 
the more active isomer of atropine, 1-hyoscyamine. In addition, the 
effects of these agents on spontaneous electrocortical activity and on 
spontaneous psychomotor activity were studied in an effort to clarify 
some of the relevant variables. For purposes of clarity the data will 
be presented as four separate experimental section. 
Experiment I 
The effects of cholinergic blocking drugs on the acquisition 
of a conditioned avoidance response 
Methods. Eighty-four male rats (]=Ioltzmann), ranging from 48 to 
62 days of age, served as the subjects. They were randomly assigned, 
with the restriction of equal numbers, to 7 groups receiving 0.13 or 
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1.05 mg/kg scopolamine hydrobromide, 1.0 or 8.0 mg/kg 1-hyoscyamine 
hydrobromide, 2.1 or 16.8 mg/kg methyl  atropine nitrate ~, or physiological 
saline. All doses were as base and were given subcutaneously. On the 
basis of data  in the literature, it was assumed tha t  scopolamine is 
approximately eight times as potent as 1-hyoseyamine. Calculating on 
a molar basis, therefore, the mg/kg ratio of scopolamine to 1-hyoscyamine 
chosen was one-eighth. Methyl atropine doses were twice that  of 1-hyos- 
eyamine. All injections were of equal volume. 
Twenty-five minutes after injection, the animals were placed in the 
experimental compartment,  which housed a modified pole-jump apparatus 
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l~ig. 1, Effects of various cholinergic blocking drugs on acqui- 
sition of a pole-jump response. ~eans and standard errors 
for trials to criterion are presented for each agent 
(Cook and W E I D I ~ E Y  
1957). The compartment  
was 45 em by 45 cm and 
had a grid floor. After 
5 rain of exposure, the 
rats  were trained on a 
conditioned avoidance 
schedule. The condi- 
tioned sthnulus (CS), a 
buzzer, was presented 
for 5 see and then over- 
lapped for 5 sec with 
the unconditioned sti- 
mulus (US), a 1.0ma. 
"scrambled" shock ad- 
ministered through the grid floor. Both CS and US intervals were controlled 
by automatic timers. An avoidance response of jumping onto the pole 
during the CS interval activated a mieroswiteh which terminated the 
buzzer and prevented the onset of the US. An escape response during 
the US interval terminated bo*h the CS and US. Intertr ial  intervals 
ranged from 20 sec. to 2 rain with an average of 1 rain. The criterion 
for acquisition was 9 avoidance responses within 10 consecutive trials. 
Failure to achieve criterion within 75 trials was arbitrarily designated 
as the terminal point of training. The pole-jump apparatus was enclosed 
in a sound-reducing box with a one-way mirror, which permit ted 
observation of the animals. 
Results. The various groups differed significantly (p ~ .001 ; Kruskal-  
Wallis one-way analysis of variance; SIEGEL 1956) on the measure of 
trials to criterion (Fig. 1). Although the methyl  atropine groups achieved 
criterion as rapidly as the saline group (p~.05;  one-tailed Mann- 
Whitney U test  ; SIEGEL 1956), significant retardation in acquisition was 
z The methyl atropine was ~ndly supplied by Dr. C. PFEIFFER (New Jersey 
Psychiatric Institute, Princeton, :N.J.). 
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observed with the low (0.13 mg/kg scopolamine and 1.0 mg/kg 1-hyoscy- 
amine; p <  .01) and high doses (1.05 mg/kg scopolamine and 8.0 mg/kg 
1-hyoscyamine; p <  .001) of the drugs with potent central actions. In 
fact, only one animal receiving 8.0 mg/kg 1-hyoseyamine and none of 
those receiving 1.05 mg/kg scopolamine achieved criterion. Among the 
scopolamine and 1-hyoscyamine groups, only the difference in perform- 
anee between the 0.13 mg/kg and 1.05mg/kg scopolamine groups 
approached significance ( p =  .05). The failure to find clear differences 
on the number of trials to criterion among these groups almost certainly 
resulted from the restriction of such differences imposed by the arbitrary 
terminal point of training 
at 75 trials. 
Reference to the per- 
centage of avoidance 
responses made during 
acquisition (Fig. 2) is also 
revealing. Again, the 
groups differed (/) < .001). 
In addition to the per- 
formance disparities men- 
tioned above (which were 
again evident by this 
measure), the beha~dor 
of the low dose groups 
was different from that 
of the high dose groups 
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Fig, 2. Effects of various oholinergie blocking drugs on 
the percentage of avoidance responses. Means and standard 
errors are presented for each agent 
for both 1-hyoseyamine and scopolamine. The 0.13 mg/kg scopolamine 
animals avoided more often than the 1.05 mg/kg scopolamine animals 
( p <  .025), as did the 1.0 mg/kg 1-hyoseyamine animals compared to 
the 8.0 mg/kg 1-hyoscyamine animals (p <.001). The performance of the 
low dose scopolamine and 1-hyoseyamine groups was indistinguishable, 
as was the performance of the two high dose groups (p >.05). The data 
on average response latencies demonstrated the same differences found. 
with percentage avoidance and therefore is not presented. 
These dose-response effects on percentage avoidance reflected two 
facts. First, only two of the 8.0 mg/kg 1-hyoscyamine animals and none 
of the 1.05 mg/kg scopolamine animals emitted any avoidance responses. 
Secondly, many animals in both the 0.13 mg/kg scopolamine and 
1.0 mg/kg 1-hyoseyamine groups often vacillated back and forth between 
emitting a series of avoidanee responses and emitting either escape 
responses or no responses at all. This behavior was rarely seen in control 
animals. Thus, the animals in these two groups required many trials to 
achieve criterion but, in the process, often made avoidance responses. 
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Experiment II 
The effects of cholinergic blocking drugs on the retention 
of a conditioned avoidance response 
Methods. Seventy-two male rats (I-Ioltzmann), ranging in age from 
48 to 59 days at the start of the experiment, served as subjects. They 
were randomly assigned in equal numbers to 6 groups, 4 of which 
received scopolamine hydrobromide or 1-hyoscyamine hydrobromide in 
the same doses used in Experiment I. One control group again received 
physiological saline while the last group was injected with 1.10 mg/kg 
N-methyl scopolamine bromide (Pamine) 1 as base. All animals 
were trained, again on the pole-jump avoidance response, for 4 con- 
secutive days. Training on the first day was identical to that in the 
acquisition study except that  no drugs were administered. On the 
second and third days, the animals were retrained to the original criterion. 
On the fourth day, the animals were injected with the various drugs 
and then, after 1/2 hr., given 20 retention trials with shock reinforcement. 
Results. As an index that  training was the same for all groups, 
performance on the first three days of training was averaged and com- 
pared. The various groups did not differ (p>.05)  on the measures of 
trials to criterion, percentage avoidance, or average response lateneies. 
Performance on the fourth, or retention, day was evaluated by the 
measures of percentage avoidance and average response latencies. Minor, 
but nevertheless significant, differences were found among the groups 
on percentage avoidance (Table 1). The saline animals made more 
Table 1. E//ects o/various cholinergic blocking agents on the retention o/the pole jump 
response. On days 1--2 the percentage avoidance responses to achieve criterion are 
listed. The drugs were given on day d 
Drug 
S~l ine  . . . . . . . .  
0.13 Scopolamine 1 . . 
1.05 Scopolamine . . . 
1.1 Methyl scopolamine 
1.0 1-Hyoscyamine . . 
8.0 1-tIyoseyamine . . 
1 Doses in mg/kg S.C. 










(16) 86 (20) 
(20) 92 (9) 
(18) 91 (8) 
(18) 93 (9) 
(17) 86(16) 














avoidance responses than the 1.05 mg/kg scopolamine animals (p <.01) 
and than the 1.0 mg/kg 1-hyoscyamine animals (p <.05). Similarly, 
the 8.0 mg/kg 1-hyoscyamine animals avoided more often than the 
1 The Pamine was generously supplied by Dr. WEBB (Upjohn Co., Kalamazoo, 
Michigan). 
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1 .05mg/kg  scopolamine ( p < . 0 1 )  and  the  1 .0mg/kg  1-hyoscyamine  
(p  ~ .025)  animals .  
Conversely,  there  were no signif icant  differences among  groups on the  
measure  of average  response latencies on the  re ten t ion  tes t  (Table 2). 
I t  would  appea r  t h a t  th is  measure ,  r a t h e r  t h a n  percentage  avoidance ,  
is the  more  meaningfu l  one. This is because the  l a t ency  measure  t akes  
account  of more  of t he  da ta .  Tha t  is, an escape response wi th  a shor t  
la tency,  ind ica t ing  some degree of re tent ion ,  is lost  wi th  the  measure  
of percentage  avoidance,  b u t  no t  wi th  t h a t  of average response latencies.  
Thus  r e t en t ion  of a condi t ioned avo idance  response is essent ia l ly  un- 
impa i r ed  b y  cholinergic blocking drugs in the  doses used here. 
Table 2. E//ects o] various cholinergic blocIcing agents on the retention o/the pole lump 
response. On days 1--3 the mean latency o/responses to achieve criterion is listed. The 
drugs were given on day d 
Drug 
Saline . . . . . . . .  
0.13 Scopolamine 1 . . 
1.05 Scopolamine . . . 
1.1 Methyl scopolamine 
1.0 1-Hyoscyamine . . 
8.0 1-ttyoscyamine . . 
1 Doses in mg/kg S.C. 
5~:can response latency (in sec) -' S.E. 
Days 


























Exper iment  I I I  
The effects o~ cholinergic blocking drugs on spontaneous activi ty 
Methods. Fo r ty -n ine  male  ra t s  (Hol tzmann) ,  ranging from 54 to 
57 days  of age when the  exper imen t  began,  served as subjects .  They  
were r a n d o m l y  d iv ided ,  wi th  the  res t r ic t ion  of equal  numbers ,  in to  
7 groups.  On the  f irst  and  th i rd  days  of this  exper iment ,  al l  animals  
received in ject ions  of physiological  saline. On the  second day ,  however,  
t h e y  were in jec ted  with  e i ther  scopolamine,  1-hyoscyamine,  or m e t h y l  
a t ropine.  The  doses and  rou te  of admin i s t r a t i on  were the  same as in 
E x p e r i m e n t  I ,  except  t h a t  a 2.1 mg/kg  scopolamine group was added.  
One half  hour  a f te r  in jec t ion  on each of the  th ree  days, t h e a n i m a l s  were 
p laced  in a c t i v i t y  cages for  a 1/2 hour  period.  The  cages 1 were those  
descr ibed  b y  BASTIA~ and  HILL (1957). They  were made  of pe r fo ra ted  
a l u m i n u m  and  measured  17.5 cm b y  11.5 cm b y  5 em. The cage 
b o t t o m  was ba lanced  on an  edge along i ts  shor t  dimension,  and  the  cage 
was a t t a c h e d  to  the  a r m a t u r e  of a mechanica l  counter .  Thus,  movemen t s  
of the  r a t  back  and  for th  along the  length  of the  cage were regis tered  on 
the  counter  and  an ind ica t ion  of a c t i v i t y  obta ined .  
Motor-meter (A and B Products, 463 Titonka Street, Park Forest, Ill.). 
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Results. The findings were analyzed by comparing the activity, as 
registered on the counter, on the day the drugs were administered to the 
mean activity of the two days when saline was administered (Fig. 3). 
Most of the drugs produced significant changes in the level of activity. 
All doses of scopolamine used and 1.0 mg/kg 1-hyoscyamine increased 
spontaneous activity (p =.02; two-tailed Wilcoxin sign-rank test of 
differences; STEGEL 1956). Conversely, activity was reduced after the 
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Fig. 3. Percentage change of spontaneous 
motoric activity with various cholinergie 
blocking drugs. The baseline represents the 
mean activity obtained with saline 
injection of 8.0 mg/kg 1-hyoscyamine 
(p=.02) or of 16.8mg/kg methyl 
atropine (p----.05). Only 2.1 mg/kg 
methyl atropine failed to have a 
significant effect (p ~.05). 
Comparisons (two-tailed Mann- 
Whitney-U-tests) of  the activity 
levels characteristic of the various 
drug groups revealed that the three 
scopolamine groups and the 1.0 mg/kg 
1-hyoscyamine group did not differ 
among themselves (p ~.62), but did 
differ from the two methyl atropine 
groups and the 8.0 mg/kg 1-hyoscya- 
mine group (p ~.05). In turn, these 
latter groups did not differ among 
themselves (p ~.07). 
Experiment IV 
The effects of cholinergic blocking drugs on spontaneous 
eleetrocortieal activity 
Methods. Thirteen mature, male rats (Holtzmann), ranging in 
weight from 230 to 430 gin, were used. The animals were anesthetized 
with diethyl ether and the trachea exposed surgically and eannulated for 
artificial respiration. The animals were then given 2 to 3 mg/kg d-tubo- 
curarine intraperitoneally, placed on artificial respiration, and the 
diethyl ether anesthesia discontinued. All wound edges were infiltrated 
with 1% xyloeaine. Eleetrocorticograms (ECG) were recorded mono- 
polarly from bilateral, somatosensory cortical areas through the use of 
small phonograph needles. After infiltration with xylocaine, the scalp 
was incised at the midline and retracted. The electrodes were gently 
pounded into the calvarium to barely make contact with the dura. 
At least 1 hr. was allowed to intervene between the end of ether anesthesia 
and the beginning of the experiments. 
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After injecting physiological saline and obtaining control records, 
the effects of scopolamine, 1-hyoscyamine, and methyl atropine on the 
ECG were determined. The doses o5 the drugs were the same as those used 
in Experiment I. Typically, animals received more than one dose of 
a drug (with at least 1 hr. interposed between injections), but  no animal 
was ever given more than one drug. At least three experiments were 
performed with each dose. All injections were given subcutaneously. 
The recordings were taken with either an Offner Type 1% Dynograph or on 
a Grass Model I I I  C electroencephalograph. 
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~'ig. 4. Effects  of var ious  cholinergic blocking agen t s  on the ECG of the ra t .  3r recordings 
of the  ECG of the  r igh t  somatosensory  a rea  to the  nose as the  reference are shown. All recordings 
were t aken  one half  hour  af ter  subcutaneous injection. The he igh t  of the  ver t ica l  bars  indicate  
200 microvol ts  and  the  length  of the  hor izonta l  bar  1 sec 
Results. Compared to the recordings obtained with saline, all of the 
drugs in the doses used had some effect on the ECG (Fig. 4). In all cases, 
this effect was in the direction of higher amplitude and slower frequency. 
Often there appeared to be an increased synchrony of the waves. These 
phenomena were dose related and also seemed to vary with the particular 
drug. Thus, the lower of the two doses of each drug did not have a very 
dramatic effect while the higher dose usually produced a marked change. 
Scopolamine was more effective than methyl atropine. These ECG 
changes were always present at 30 rain postinjection and persisted for 
at least another 20 to 25 rain. 
Discussion 
The major finding of this study is that  musearinic cholinergic 
blocking drugs specifically 1-hyoscyamine and scopolamine, markedly 
disrupt the acquisition, but not the retention, of a conditioned avoidance 
response. The ineffectiveness of methyl atropine and methyl scopol- 
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amine, which have cholinergie blocking actions primarily at peripheral 
sites, for altering the behaviors studied indicates that  the action is on 
the central nervous system. Thus the results confirm previous findings 
(tIs~z 1960; M~CHS~LSON (1961). 
Although some effect of scopolamine and 1-hyoseyamine on retention 
was observed, it is felt that  retention was essentially unimpaired (see 
Results, Experiment II). Had the animals been given more training 
prior to being tested for retention, it is probable that  no disruption 
whatsoever would have occurred. Indeed, tI~gz, who trained his 
animals 8 t-o 12 days before testing for retention, not only found no 
impairment with scopolamine, but even a suggestion of enhanced 
performance. I t  would appear, therefore, that  cholinergic blocking 
drugs fail to degrade conditioned avoidance behavior to the extent to 
which it is overtrained or consolidated. 
The present findings on spontaneous activity indicate that  the poor 
performance during acquisition by some of the groups was not due to 
a gross motoric depression. In fact, among the experimental groups 
only 8.0 mg/kg 1-hyoscyamine reduced activity significantly, while 
increased activity was noted for the other groups. Moreover, a significant 
decrease in activity was observed for the 16.8 mg/kg methyl atropine 
group, yet their acquisition of the conditioned avoidance response was 
unimpaired. Furthermore, it does not seem likely that  changes in activity 
would disrupt acquisition while failing to affect retention. 
Additionally, the data on spontaneous activity have intrinsic 
interest. Although cholinergic blocking drugs, especially scopolamine, 
have a sedative effect on humans (GooD31AN and GILMAN 1955; OSTF]~LD 
et al. 1960), they appear to act in rats as psychomotor stimulants in at 
least some of the doses used. The relatively slight effect of methyl 
atropine in altering activity implies a central nervous system site of 
action of 1.hyoseyamine and scopolamine. This finding validates similar 
incidental observations on the effect of scopolamine in rabbits (SADoWSKI 
and LONGO 1962). The data also suggest an inverted U type of effect, 
i.e., the existence of an optimal dose for increasing spontaneous activity 
with larger doses either having a lesser effect or even depressing activity. 
Such a relationship can be inferred from data previously reported 
(MAcHT 1924). 
The ECG results imply confirmation of previous observations of the 
"dissociation" of ECG and behavior (WIxL~R 1952; BgADL]SY and 
ELKES 1957). In doses which produced ECG patterns typical of som- 
nolence or coma, rats did not necessarily display a depression of gross 
or learned behavior. For example, although 1.0 mg/kg scopolamine 
produced increased psychomotor activity while 8.0 mg/kg 1-hyoseyamine 
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produced a decrease of such activity, both agents created similar high 
voltage, slow activity in the ECG. In fact, this dose of scopolamine 
appeared to have an even more potent effect than 1-hyoscyamine in 
producing such ECG activity. Although 16.8 mg/kg of methyl atropine 
caused marked slowing of the EC G, it failed to alter conditioned avoidance. 
Furthermore, all of the doses of scopolamine and 1-hyoseyamine used 
had a dramatic effect on the acquisition, but not on the retention, of a 
conditioned avoidance response. Yet, it can be presumed that  the effects 
of these drugs on the cortical activity of the animals was the same re- 
gardless of whether they were initially acquiring or demonstrating 
retention of this learned response. 
Thus, it can be concluded that  the ECG as affected by cholinergic 
blocking drugs is not helpful in analyzing the mechanisms involved in 
regulating this type of behavior. There is, in fact, a "dissociation" 
between the ECG and behavior. I t  is not clear at this time, however, 
whether the ECG, as recorded with maeroeleetrodes, is too gross a 
technique to have relevance for pharmacologically manipulated behavior 
or if cortical structures are relatively unimportant for the behavior 
studied. Perhaps the critical site of action of cholinergic blocking drugs 
is subcortical rather than cortical. 
The hypothesis of CARLTON (1963), concerning the function 
of cholinergic systems, does not appear adequate for explaining the 
results of the conditioned avoidance experiments. He suggests that  
central eholinergie systems are inhibitory and arc in a reciprocal balance 
with adrenergie systems which arc excitatory. Since cholincrgic systems 
are posited to normally inhibit unreinforced responses, the administra- 
tion of cholinergic blocking drugs should result in their release. This 
explanation might fit the acquisition data since retarded learning can 
be conceived of as the continued emission of unreinforeed responses. 
However, it would appear that  this hypothesis cannot explain the 
failure of these drugs to disrupt retention as well  
A more probable explanation is that  eholinergic blocking drugs impair 
recent memory. As mentioned above, these drugs do have amnesic 
properties in humans (GooD~A~ and GrL~IA~ 1955; MIGDAL and FRUMIN 
1963; OSTFnLD et al. 1960). The dichotomous effect of these agents on 
acquisition and retention of a learned response can also be conceived 
of as involving recent memory. During acquisition the animal must 
remember from one trial to the next which responses were appropriate and 
which inappropriate. Conversely, during retention the animal can be 
presumed to have available a well-consolidated memory trace, acquired 
in the past and independent of recent memory. Finally, the behavior of 
vacillating back and forth between making avoidance responses and 
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making no such responses, which was characteristic of the low dose 
scopolamine and 1-hyoseyamine animals during acquisition, is highly 
suggestive of a recent memory deficit. It  appeared as if they would 
discover the correct response, forget it, rediscover it, and so forth. 
Hypotheses concerning a possible site of action of these drugs must, 
at this time, be highly speculative. I t  can be stated that the site is in the 
central nervous system since methyl atropine, although having some 
central effects (PAvL-DAvID et al. 1960; also Results, Experiment IV), 
was relatively ineffective in altering the behaviors studied. Within the 
central nervous system, cholinergic blocking drugs probably have 
widespread effects. If it is correct that muscarinic cholincrgic systems 9 
are implicated in the process of recent memory, however, it may be 
that a critical site of action is in medial temporal structures. These 
structures, and particularly the hippocampus, appear to be intimately 
associated with the process of recent memory (ScovILLE and MILNm~ 
1957; WA~KEX 1957; PE~FIELD and MIL~EI~ 1958; STErlEN et al. 1960; 
FLEXNEI~ et al. 1963). Also, rats with hippocampal lesions display 
increased spontaneous activity (TEITEL]3AOM and MIL~ER 1963), as did 
rats treated with most of the doses of cholinergic blocking drugs in the 
present study. Moreover, the findings demonstrating a high concentra- 
tion of endogenous acetylcholine in the hippocampus (FELD]~m~G and 
VoGT 1948; Gm~EBTZOFF 1959; HEB]3 and SILVm~ 1956) indicate the 
availability of this structure as a site of action. Thus it is suggested 
that the possibility be investigated that the hippocampus is an im- 
portant component of a musearinic cholinergic system. 
Summary 
Results are presented for the effects of drugs with muscarinie 
cholinergic blocking actions, both central and peripheral (scopolamine 
and 1-hyoscyamine) and primarily peripheral (methyl atropine and 
methyl scopolamine), on conditioned avoidance behavior, spontaneous 
motor activity, and the ECG in the rat. 
Low doses of the agents with central actions retarded acquisition of 
conditioned avoidance, while high doses virtually abolished it. Both low 
and high doses were essentially ineffective in altering retention of 
conditioned avoidance. Agents with primarily peripheral actions had 
no effect on acquisition or retention. 
Most of the agents produced an increase in spontaneous activity 
although there was a definite suggestion that higher doses depress 
activity. 
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All of the agents used provoked a high ampli tude,  slow frequency 
ECG. This phenomenon  was dose-related; scopolamine appeared to be 
most  effective. 
I t  is suggested t ha t  the disrupt ion of the acquisit ion, bu t  not  re tent ion,  
of condit ioned avoidance is due to a deficit of recent  memory.  A possible 
site of act ion of cholinergic blocking drugs is proposed. 
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